Member Info for Soupdragon78

Such desperation... chill out NFT's.

Man who said this would crash in July now says december

Good read in this paper from Boehringer.

Covers ground as to how the IPF treatment scene is changing to combination therapies with short trial spans

https://www.frontiersin.org/articles/10.3389/fphar.2022.823085/full

Again, so worked up for someone with no interest here.

Anyway, as you’ve established. NFX submitted an amendment to the patent on July 21st, deleting claims 11 and 12 in compliance with the patent officer.

But hey, you obviously knew that.

Well done NFTs we are getting somewhere.

So, since the refusal only relates to claims 11 and 12, can you tell me what amendment to the patent NFX have submitted?

Now NFT's, lets look at what you actually copy pasted.

This is from your post.

"At present, no reasons for refusal are found with respect to the inventions according to Claims ( 1-10,13-21 ) at present at this point."

Do you understand what that means?

NFT's, has the patent been categorically rejected with no chance of appeal or amendment? No, its still in progress.

Its as simple as that.

As I said, with your research, you will know that this has happened before and the patent subsequently granted. Patent approval is a process, not a one off moon shot. Hence the company hasn't had to announce anything because its not reached a conclusion yet.

You can enter negotiations at anytime, it all depends on what the parties want.

Again, you seem very worked up about this for some reason on a Sunday night when its been known for months?

Again, nothing for you to worry about is there. You seem very worked up about it for some reason, just chill out you don't hold any stock anyway.

As you will know, this has happened before with the company appealing a patent refusal for NXP002 and then subsequently being granted. I didn't hear you squeeling about that at the time.

The company hasn't hidden anything, its been in the public domain since March when it was uploaded to the WIPO website. I talked about it months ago when you were still holding.

Thanks NFTs we've covered the patent side of things a few days ago, they've removed the clause as requested by the examiner.

Nothing for you to worry about after all you sold at what 0.24p on 17 April?

Thanks Chab and well done on making a bit here over time, also for having a 0.28p level now.

It will be what it will be.

Good to see they've appealed the Japanese patent office issues by removing the claim that the officer had an issue with.

Should progress through now.

https://patentscope.wipo.int/search/en/detail.jsf?docId=JP344317072&_fid=US339759777

And what happens if that doesn’t materialise?

So what are you going to do FX?

It’s all about messaging that they are currently in on-going discussions with potential partners on two fronts.

https://www.***************************/nuformix-excited-as-it-moves-focus-to-nxp002-and-nxp004-programmes/4121127409

on directors talk interviews if link is blocked

Video interviews are usually done on the morning and posted in the afternoon. They need editing etc, so not instant.

As I mentioned a couple of months ago, Oxilio have likely around £700k cash, so it was never going to be huge amounts.

I reckon circa 100k they will have paid for the patents. (Based on nothing but my own guesstimate)

Would have hoped they’d go for more like 500k but as NfX have kept the royalty side in place I doubt it.

Also Oxilio have recently employed a Clinical Trials Administrator, so they signs are it’s moving forward soon.

Good to see them getting some form of immediate payment for nxp001 although undisclosed.

I see Small Pharma, the company Alastair Riddell scarpered to has been bought up by Cybin for around £17m.

https://smallpharma.com/press-release/cybin-to-acquire-small-pharma/